Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines.
Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines.
复制标题
DOI:
10.1016/j.bbrc.2012.06.047
复制
发表时间:
2012-07-13
影响因子:
3.1
通讯作者:
Fong, Miranda Y.
中科院分区:
文献类型:
--
作者:
Kakar, Sham S.;Jala, Venkatakrishna R.;Fong, Miranda Y.
Cisplatin derivatives are used as the mainline treatment of ovarian cancer, despite their severe side effects and development of resistance. We developed a novel combination therapy by combining cisplatin with withaferin A. Treatment of ovarian cancer cell lines with combination therapy acted synergistically to induce cell death, thus required a lower dose of cisplatin to achieve the same therapeutic effect. WFA and cisplatin combination induced cell death through the generation of reactive oxygen species (ROS) for WFA, while DNA damage for cisplatin, suggesting that cisplatin binds directly to DNA to form adducts while WFA indirectly damages DNA through ROS generation. Our results for the first time suggest that combining low dose of cisplatin with suboptimal dose of WFA can serve as a potential combination therapy for the treatment of ovarian cancer with the potential to minimize/eliminate the side effects associated with high doses of cisplatin.
登录
查看更多内容
DOI:
10.12659/msm.881894
发表时间:
2011-08
期刊:
Medical science monitor : international medical journal of experimental and clinical research
影响因子:
--
作者:
Lorito G;Hatzopoulos S;Laurell G;Campbell KC;Petruccelli J;Giordano P;Kochanek K;Sliwa L;Martini A;Skarzynski H
通讯作者:
Skarzynski H
DOI:
10.1152/ajprenal.1996.270.4.f700
发表时间:
1996-04-01
期刊:
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY
影响因子:
--
作者:
Lieberthal, W;Triaca, V;Levine, J
通讯作者:
Levine, J
影响因子:
4.7
作者:
Munagala, Radha;Kausar, Hina;Gupta, Ramesh C.
通讯作者:
Gupta, Ramesh C.
影响因子:
7.2
作者:
Mayola, Eleonore;Gallerne, Cindy;Lemaire, Christophe
通讯作者:
Lemaire, Christophe
影响因子:
7.5
作者:
Mazure, Nathalie M.;Pouyssegur, Jacques
通讯作者:
Pouyssegur, Jacques